Skip to main content
SpringerLink
Log in

Alzheimer

  • Chapter
Self Management of Chronic Disease

  • 1350 Accesses

Abstract

On November 3rd 1906, Aloys Alzheimer presented to the Meeting of the Psychiatrists the neuropathological and clinical features of Auguste D., who had died of dementing illness at the age of 55. The disease was given its eponym by his senior colleague E. Kraepelin. The description initiated the slow separation between Alzheimer’s disease (AD) and other causes of presenile dementia (Hardy 2006).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Bidzan L, Turczynski J (2005) Environment and cognitive functions in a population 60 years and older (Prevalence of dementia in a rural population). Psychiatr Pol 39; 1211–1218

    PubMed  Google Scholar 

  • Cacabelos R (2007) Molecular pathology and pharmacogenomics in Alzheimer’s disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression. Methods Find Exp Clin Pharmacol 29: Suppl A

    Google Scholar 

  • Campbell DE, Lynn J., Louis TA, Shugarman LR (2004) Medicine program expenditures associated with hospice use. Ann Intern Med 140: 269–277

    PubMed  Google Scholar 

  • Clegg A, Bryant J, Nicholson T (2001) Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer’s disease: A rapid and systematic review. Health Technol Assess 5: 1–137

    Google Scholar 

  • Das SK, Biswas A, Roy T et al. (2006) A random sample survey for prevalence of major neurological disorders in Calcutta. Indian J Med Res 124: 163–172

    CAS  Google Scholar 

  • Dong MJ, Peng B, Lin XT et al. (2007) The prevalence of dementia in the People’s Republic of China: a systematic analysis of 1980–2004 studies. Age Ageing 36: 619–624

    Article  PubMed  Google Scholar 

  • Ferri CL, Prince M et al. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366: 2112–2117

    Article  PubMed  Google Scholar 

  • Ferri CP, Prince M, Brayne C et al. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366: 2112–2117

    Article  PubMed  Google Scholar 

  • Gabryelewicz T (1999) The prevalence of dementia in the population of the Warsaw district of Mokotow from 65 to 84 years of age. Psychiatr Pol 33: 353–366

    PubMed  CAS  Google Scholar 

  • Giacobini E (2006) Cholinoesterases in human brain: the effect of cholinesterase inhibitors on Alzheimer’s disease and related disorders. In: Giacobini E, Pepeu G (eds) The brain cholonergic system in health and disease. Informal Healthcare, Oxon, pp 235–264

    Google Scholar 

  • Glaser A (2008) Merz Pharmaceuticals, Frankfurt. http://www. merz.de/presse/pressemappen_gesundheit/alzheimer/verlauf/

    Google Scholar 

  • Hardy J (2007) A hundred years of Alzheimer’s disease research. NEURON 52:3–13

    Article  CAS  Google Scholar 

  • Hofman A et al. (1991) The prevalence of dementia In Europe: a collaborative study of 1980–1990 findings. Int J Epidemiol 20: 736–748

    Article  PubMed  CAS  Google Scholar 

  • Jacob KS, Kumar PS, Gayathri K et al. (2007) The diagnosis of dementia in the community. Int Psychogeriatr 19: 669–678

    Article  PubMed  CAS  Google Scholar 

  • Loveman E, Green C, Kirby J (2006) The clinical and costeffectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer’s disease. Health Technol Assess 10: 1–176

    Google Scholar 

  • Molero AE, Pino-Ramirez G., Maestre GE (2007) High prevalence of dementia in Caribbean population. Neuroepidemiology 29: 107–112

    Article  PubMed  Google Scholar 

  • Ogeng’o JA, Cohen DL, Sayi JG (1996) Cerebral amyloid beta protein deposits and other Alzheimer lesions in nondemented elderly east Africans. Brain Pathol 6: 101–107

    Article  CAS  Google Scholar 

  • Prince M, Acosta D, Chiu H, Scazufca M, Varghese M (2003) Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361: 909–917

    Article  PubMed  Google Scholar 

  • Prince M, Ferri CP, Acosta D (2007) The protocols for the 10/66 Dementia Research Group population-based research programme. BMC Public Health 2: 165

    Article  Google Scholar 

  • Prince MJ (1997) The need for research on dementia in developing countries. Trop Med Int Health 2: 993–1000

    PubMed  CAS  Google Scholar 

  • Raicher I, Shimizu MM, Takahashi DY et al. (2008) Alzheimer’s disease diagnosis disclosure in Brazil: a survey of specialized physicians’ current practice and attitudes. Int Psychogeriatr 20: 471–481

    Article  PubMed  Google Scholar 

  • Rodriguez JJL, Ferri CP, Acosta D et al. (2008) The prevalence of dementia in Latin America, India and China. A 10/66 Dementia Research Group population-based survey. Lancet 372: 464–474

    Article  PubMed  Google Scholar 

  • Rossa G (1997) The prevalence of Alzheimer’s type dementia and vascular dementia in the district of Swieboclzin. Psychiatr Pol 31: 121–134

    PubMed  CAS  Google Scholar 

  • Suh GH, Shah A (2001) A review of the epidemiological transition in dementia-cross-national comparisons of the indices related to Alzheimer’s disease and vascular dementia. Acta Psychiatr Scand 104: 4–11

    Article  PubMed  CAS  Google Scholar 

  • Tschanz JT (2006) Conversion to dementia from mild cognitive disorder. Neurology 67: 2

    Article  Google Scholar 

  • Waldemar G, Phung KT, Burns A et al. (2007) Access to diagnostic evaluation and treatment for dementia in Europe. Int J Geriatr Psychiatry 22: 47–54

    Article  PubMed  Google Scholar 

  • Wender M, Mularczyk J, Modestowicz R (1990) Epidemiology of Alzheimer’s disease in the selected region of Wielkopolska (town and commune Steszew). Przegl Epidemiol 44: 215–221

    PubMed  CAS  Google Scholar 

  • WHO (2002) Active ageing: a policy framework, 2002 health report. World Health Organization, Geneva

    Google Scholar 

  • Wimo A, Jonsson L, Winbaad B (2006) An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord 21: 175–181

    Article  PubMed  CAS  Google Scholar 

  • Zhang ZX, Zahner GE, Roman GC, et al. (2006) Socio-demographic variation of dementia subtypes in china: methodology and results of prevalence study in Beijing, Chengdu, Shanghai, and Xian. Neuroepidemiology 27: 177–187

    Article  PubMed  Google Scholar 

References

  • Alf C, Bancher C, Benke T, Berek K et al. (2006) Konsensusstatement “Demenz” der Österreichischen Alzheimer Gesellschaft, update 2006. Neuropsychiatrie 2006; 20: 221–221

    Google Scholar 

  • Areosa SA, Sherriff F, McShane R (2005) Memantine for dementia. Cochrane Database Syst Rev 3: CD003154

    PubMed  Google Scholar 

  • Bassuk SS, Glass TA, Berkman LF (1999) Social disengagement and incident cognitive dedine in community-dwelling elderly persons. Ann Intern Med 131: 165–173

    PubMed  CAS  Google Scholar 

  • Bowie P, Branton T, Holmes J (1999) Should the Mini Mental State Examination be used to monitor dementia treatments? Lancet 354: 1527–1528

    Article  PubMed  CAS  Google Scholar 

  • Campbell Ss, Dawson D, Anderson MW (1993) Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc 8: 829–836

    Google Scholar 

  • Cardinali DP, Brusco LI, Liberczuk C, Furio AM (2002) The use of melatonin in Alzheimer’s disease. Neuro Endocrinol Lett Suppl 1: 20–23

    Google Scholar 

  • Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N (2002) Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer’s disease. A systematic review. Int J Technol Assess Health Care 18: 497–507

    Article  PubMed  Google Scholar 

  • Colcombe SJ, Erickson KI, Raz N, Webb AG, Cohen NJ, McAuley E, Kramer AF (2003) Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 58: 176–180

    PubMed  Google Scholar 

  • Colcombe SJ, Kramer AF, Erickson KI et al. (2004) Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci USA 101: 3316–3321

    Article  PubMed  CAS  Google Scholar 

  • Cummings JL (2004) Drug therapy: Alzheimer’s Disease. N Engl J Med 351: 56–67

    Article  PubMed  CAS  Google Scholar 

  • Dantoine T, Auriacombe S, Sarazin M, Becker H, Pere JJ, Bourdeix I (2006) Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer’s disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J clin Pract 60: 110–118

    Article  PubMed  CAS  Google Scholar 

  • Doody RS, Stevens JC, Beck C et al. (2001) Practice Parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1154–1166

    PubMed  CAS  Google Scholar 

  • Erkinjuntti T, Román G, Gauthier S, Feldman H, Rockwood K (2004) Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 35: 1010–1017

    Article  PubMed  CAS  Google Scholar 

  • Evans JG, Wilcock G, Birks J (2004) Evidence-based pharmacotherapy of Alzheimer’s disease. Int J Neuropsychopharmacol 7: 351–769

    Article  PubMed  CAS  Google Scholar 

  • FDA Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavorial Disturbances. www.fda. gov/cder/drug/advisory/antipsychotics.htm.

    Google Scholar 

  • Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 355: 1315–1319

    Article  PubMed  CAS  Google Scholar 

  • Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T et al. (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63: 1402–1408

    Article  PubMed  Google Scholar 

  • Gage FH (2002) Neurogenesis in the adult brain. J Neurosci 22: 612–613

    PubMed  CAS  Google Scholar 

  • Gaines JM, Miller KJ, Parrish JM et al. (2007) Effects of a healthy aging intervention program on older adults: The Memory Fitness Study. Poster presented at: National Gerontological Nursing Association’s 22nd Annual Conference; October 18–21, 2007; Orlando, FL

    Google Scholar 

  • Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102 1095–1104

    Article  PubMed  CAS  Google Scholar 

  • Glass TA, De Leon CF, Bassuk SS, Berkman LF (2006) Social engagement and depressive symptoms in late life: longitudinal findings. J Aging Health 18: 604–628

    Article  PubMed  Google Scholar 

  • Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jönsson L, Thijssen M, Hoefnagels WH, Rikkert MG (2006) Community based occupational therapy for patients with dementia and their care givers: randomized controlled trial. BMJ 333: 1196–1201

    Article  PubMed  Google Scholar 

  • Graff MJ, Vernooij-Dassen MJ, Thijssen M, Dekker J, Hoefnagels WH, Olderikkert MG (2007) Effects of community occupational therapy on quality of life, mood, and health status in dementia patients and their caregivers: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 62: 1002–1009

    PubMed  Google Scholar 

  • Hathcock JN (1997) Vitamins and minerals: Efficacy and safety. Am J Clin Nutr 66: 427–437

    PubMed  CAS  Google Scholar 

  • Hemmeter UM, Thum A, Krieg JC (2007) Altersinsomnie (Insomnia in the elderly), Somnologie 11: 84–98

    Article  Google Scholar 

  • Herrmann N, Gill SS, Bell CM, Anderson Gm, Bronskill SE, Shulman KI, Fischer HD, Sykora K, Shi HS, Rochon PA (2007) A population-based study of cholinesterase inhibitor use for dementia. J Am Geriatr Soc 55: 1517–1523

    Article  PubMed  Google Scholar 

  • Hills R, Gray R, Stowe R et al. (2002) Drop-out bias undermines findings of improved functionality with cholinesterase inhibitors. Neurobiol Aging 23 (Suppl 1): S89

    Google Scholar 

  • Hogan DB, Bailey P, Black S et al. (2008) Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ 179: 1019–1026

    PubMed  Google Scholar 

  • Huell M, Voigt-Radloff S (2008) Nichtpharmakologische Behandlungsmethoden bei Demenzen. Nervenarzt 79 (Suppl 3): 159–164

    Article  Google Scholar 

  • Kahn RL, Rowe JW (1998) Successful aging. Pantheon, New York

    Google Scholar 

  • Relkin NR (2008) Currents state of immunotherapy for Alzheimer’s disease. CNS Spectr 13 (Suppl 16): 39–41

    PubMed  Google Scholar 

  • Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST (2000) Validation of the NPI-Q a brief clinical form of the Neuropsychiatric Inventory. J Neropsychiatry Clin Neurosci 12: 233–239

    CAS  Google Scholar 

  • Lebert F (2003) Serotonin reuptake inhibitors in depression of Alzheimer’s disease and other dementias. Presse Med 32: 1181–1186

    PubMed  Google Scholar 

  • Man SC, Durairajan SS, Kum WF, Lu JH, Huang JD, Cheng CF, Chung V, Xu M, Li M (2008) Systematic review on the efficacy and safety of herbal medicines for Alzheimer’s disease. J Alzheimers Dis 14: 209–223

    PubMed  Google Scholar 

  • Gail A (2006) Mountain Self-management for people with early dementia, An exploration of concepts and supporting evidence. Dementia 5: 429–446

    Article  Google Scholar 

  • McDaniel MA, Maier Sf, Einstein GO (2003) Brain-specific nutrients: a memory cure? Nutrition 19: 957–975

    Article  PubMed  CAS  Google Scholar 

  • Miller LJ (2007) The use of cognitive enhancers in behavioral disturbances of Alzheimer’s disease. Consult Pharm 22: 754–762

    PubMed  Google Scholar 

  • Möller HJ (1993) Therapy of dementing diseases: value of calcium antagonists. Fortschr Med 111: 437–440

    PubMed  Google Scholar 

  • Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164: 898–906

    Article  PubMed  Google Scholar 

  • Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT; Memantine MEM-MD-12 Study Group (2008) Memantine treatment in patients with mild to moderate Alzheimer’s disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 5: 83–89

    Article  PubMed  CAS  Google Scholar 

  • Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 148: 379–397

    PubMed  Google Scholar 

  • Rocamora R, Thum A, Giesler M, Haag A, Becker A, Dodel R, Penzel T, Krieg J, Hemmeter U (2005) Schlafstörungen bei degenerativen Demenzen. Somnologie 9: 139–147

    Article  Google Scholar 

  • Roth T, Stubbs C, Walsh JK (2005) Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep 28: 303–307

    PubMed  Google Scholar 

  • Seltzer B (2007) Is long-term treatment of Alzheimer’s disease with cholinesterase inhibitor therapy justified? Drugs Aging 24: 881–890

    Article  PubMed  CAS  Google Scholar 

  • Small GW, Silverman DH, Siddarth P et al. (2006) Effects of a 14-day healthy longevity lifestyle program on cognition and brain function. Am J Geriatr Psychiatry 14: 538–545

    Article  PubMed  Google Scholar 

  • Small GW, Siddarth P, Burggren AC et al. (2009) Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry 66: 81–87

    Article  PubMed  Google Scholar 

  • Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I; Memantine Study Group (2004a) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291: 317–324

    Article  PubMed  CAS  Google Scholar 

  • Tariot PN, Profenno LA, Ismail MS (2004b) Efficacy of atypical antipsychotics in elderly patients with dementia. J Clin Psychiatry 65 (Suppl 11): 11–15

    PubMed  CAS  Google Scholar 

  • Unnebrink K, Windeler J (2001) Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat Med 20: 3931–3946

    Article  PubMed  CAS  Google Scholar 

  • Werheide K, Thöne-Otto AIT (2006) Kognitives Training bei Alzheimer Demenz. Nervenarzt 77: 549–557

    Article  Google Scholar 

  • Wiegand MH (2003) Drug treatment of sleep disorders in the elderly. Internist (Berl) 44: 1187–1192

    Article  CAS  Google Scholar 

  • Winblad B (2005) Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev 11: 169–182

    PubMed  CAS  Google Scholar 

References

  • Adams T (1996) Kitwood’s approach to dementia and dementia care: a critical but appreciative review. J Adv Nurs 23: 948–953

    Article  PubMed  CAS  Google Scholar 

  • Adler A (1972) Über den nervösen Charakter. Fischer, Frankfurt am Main

    Google Scholar 

  • Ballenger JF (2006) Progress in the history of Alzheimer’s disease: The importance of context. J Alzheimer’s Dis 9: 5–13

    CAS  Google Scholar 

  • Bauer J (1997) Möglichkeiten einer psychotherapeutischen Behandlung bei Alzheimer-Patienten im Frühstadium der Erkrankung. Nervenarzt 68: 421–424

    Article  PubMed  CAS  Google Scholar 

  • Bauer J, Bauer H, Teising M (1994) Psychosomatische Aspekte der Alzheimer-Demenz (pp. 47–61). In: Hirsch R (Ed.) Psychotherapie bei Demenzen. Steinkopff, Darmstadt

    Google Scholar 

  • Bauer J, Qualmann J, Bauer H (1994) Psychosomatische Aspekte bei der Alzheimer Demenz und bei vaskulären Demenzformen (pp. 214–228). In: Heuf G, Kruse A, Nehen H-G, Radebold H (Eds.) Interdisziplinäre Gerontopsychosomatik. MMV Medizin Verlag, Vieweg

    Google Scholar 

  • Bauer J, Stadtmuller G, Qualmann J, Bauer H (1995) Premorbid psychological processes in patients with Alzheimer’s disease and in patients with vascular dementia. Z Gerontol Geriatr 28: 179–189

    PubMed  CAS  Google Scholar 

  • Bayer-Feldmann C, Greifenhagen A (1995) Group work with relatives of Alzheimer patients — a systemic approach. Psychother Psychosom Med Psychol 45: 1–7

    PubMed  CAS  Google Scholar 

  • Carneiro P, Crawford C, Goodman A (2007) The impact of early cognitive and non-cognitive skills on later outcomes. Centre for the Economics of Education London School of Economics, London

    Google Scholar 

  • Carneiro P, Meghir C, Parey M (2007) Maternal education, home environments and the development of children and adolescents. IZA Institute for the Study of Labor, Bonn

    Google Scholar 

  • Damasio AR (2003) Der Spinoza-Effekt: Wie Gefühle unser Leben bestimmen. List, München

    Google Scholar 

  • Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R (1996) Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry 53: 175–182

    PubMed  CAS  Google Scholar 

  • Eisenberg L (1999) Does social medicine still matter in an era of molecular medicine? J Urban Health 76: 164–175

    Article  PubMed  CAS  Google Scholar 

  • Erikson HE (1981) The life cycle completed. Norton, New York

    Google Scholar 

  • Erlich HS, Blatt SJ (1985) Narcissism and object love. The metapsychology of experience. Psychoanal Study Child 40: 57–79

    PubMed  CAS  Google Scholar 

  • Forsythe E (1990) Alzheimer’s Disease. The long bereavement. Faber and Faber, London

    Google Scholar 

  • Gidley I, Shears R (1988) Alzheimers. What it is how to cope. Unwin, London Sydney Wellington

    Google Scholar 

  • Hanson BG (1989) Definitional deficit: a model of senile dementia in context. Fam Process 28: 281–289

    Article  PubMed  CAS  Google Scholar 

  • Hanson BG (1991) Parts, players, and »patientin«: The social construction of senile dementia. Family Systems Medicine 9: 267–274

    Article  Google Scholar 

  • Havighurst RJ (1953) Developmental tasks and education. David McKay, New York

    Google Scholar 

  • Hodges JR (2006) Alzheimer’s centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain 129: 2811–2822

    Article  PubMed  Google Scholar 

  • Hoffmann S (2008, Nov.) Meine Mutter, wie ein Kind (pp. 48–53). Chrismon, Hansisches Druck-und Verlagshaus, Frankfurt am Main

    Google Scholar 

  • Huether G, Doering S, Rüger U, Rüther E, Schüssler G (1996) Psychische Belastungen und neuronale Plastizität. Z Psychosom Med 42: 107–127

    CAS  Google Scholar 

  • Keady J, Ashcroft-Simpson S, Halligan K, Williams S (2007) Admiral nursing and the family care of a parent with dementia: using autobiographical narrative as grounding for negotiated clinical practice and decision-making. Scand J Caring Sci 21: 345–353

    Article  PubMed  Google Scholar 

  • Kitwood T (1987a) Dementia and its pathology: in brain, mind or society? Free Associations 8: 81–93

    Google Scholar 

  • Kitwood T (1987b) Explaining senile dementia. Free Associations 10: 117–140

    Google Scholar 

  • Kitwood T (1990) Understanding senile dementia — a psychobiographical approach. Free Associations 19: 60–76

    Google Scholar 

  • Kitwood T, Bredin K (1992) Towards a theory of dementia care: personhood and well-being. Ageing Soc 12: 269–287

    Article  PubMed  Google Scholar 

  • Kokmen E, Beard CM, Chandra V, Offord K-P, Schoenberg BS, Ballard DJ (1991) Clinical risk factors for Alzheimer’s disease: a population-based care-control study. Neurology 41: 1393–1397

    PubMed  CAS  Google Scholar 

  • Kroplunigg U (1989) Kindheit und Erziehung bei psychosomatisch Kranken. Psychother Psychosom Med Psychol 39: 168–172

    Google Scholar 

  • Kropiunigg U (1999a) Alzheimer’s Disease as a result of ≫wrong≪ compensation. J Indiv Psychol 55: 395–409

    Google Scholar 

  • Kropiunigg U (1999b) Kompensation und ephemer-fragiles Selbst: eine individualpsychologische Analyse der Alzheimer Krankheit. Z Individualpsychol 24: 186–202

    Google Scholar 

  • Kropiunigg U, Sebek K, Leonhardsberger A, Schemper M, Dal-Bianco P (1999) Psychosoziale Risikofaktoren für die Alzheimer Krankheit. Psychother Psychosom Med Psychol 49: 153–159

    PubMed  CAS  Google Scholar 

  • Lattmann UP, Wuchterl K (1992) Der Topos der Kompensation bei Alfred Adler — Anmerkungen aus der Sicht der philosophischen Anthropologie. Z Individualpsychol 17: 3–18

    Google Scholar 

  • Lewis D, Rodgers D, Woolcock M (2008) The fiction of development: literary representation as a source of authoritative knowledge. J Dev Studies 44: 198–216

    Article  Google Scholar 

  • Lunde A (2008) Lifestyle strategies may slow or prevent decline. Mayo Clinic medical information and tools for healthy living: http://www.mayoclinic.com/health/alzheimer/AZ99999

    Google Scholar 

  • McEwen BS (2008) Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583: 174–185

    Article  PubMed  CAS  Google Scholar 

  • McEwen BS (2000) Effects of adverse experiences for brain structure and function. Biol Psychiatry 48: 721–731

    Article  PubMed  CAS  Google Scholar 

  • McLuhan M (1964) Understanding Media: The Extensions of Man. McGraw-Hill, New York

    Google Scholar 

  • Meaney MJ (2001) Nature, nurture, and the disunity of knowledge. Ann NY Acad Sci 935: 50–61

    Article  PubMed  CAS  Google Scholar 

  • Miller DW (1995) The psychobiological nature of reality with a theory about Alzheimer’s. Advances 9: 69–76

    CAS  Google Scholar 

  • Roach M (1985) Another name for madness. Houghton and Mifflin, Boston

    Google Scholar 

  • Sapolsky RM (1996) Why stress in bad for your brain. Science 273: 749–750

    Article  PubMed  CAS  Google Scholar 

  • Schroots JJF (1996) Theoretical developments in the psychology of aging. The Gerontologist 36: 742–749

    PubMed  CAS  Google Scholar 

  • Shalat SL, Seltzer B, Pidcock C, Baker EL Jr (1987) Risk factors for Alzheimer’s disease: a case-control study. Neurology 37: 1630–1633

    PubMed  CAS  Google Scholar 

  • Speck CE, Kukull WA, Brenner DE et al. (1995) History of depression as a risk factor for Alzheimer’s disease. Epidemiology 6: 366–369

    Article  PubMed  CAS  Google Scholar 

  • Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205–242

    Article  PubMed  CAS  Google Scholar 

  • von Uexküll T (2001) Körper-Seins, Körper-Haben — Der Hintergrund des Dualismus in der Medizin. Psychother Psychosom Med Psychol 51: 128–133

    Article  Google Scholar 

  • Wilson RS, Barnes LL, Mendes de Leon CF et al. (2002) Depressive symptoms cognitive dedine, and risk of AD in older persons. Neurology 59: 364–370

    PubMed  Google Scholar 

  • Wittgenstein L (2003) Logisch-philosophische Abhandlung. Tractatus logico-philosophicus. Suhrkamp, Frankfurt am Main

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Wroclaw Medical University, Pasteura 10, 50-367, Wroclaw, Poland

    Jerzy Leszek Prof. Dr. & Andrzej Kiejna Prof. Dr

  2. Kantonale Psychiatrische Dienste St. Gallen, Sektor Nord, 9500, Wil/SG, Switzerland

    Ulrich Michael Hemmeter MD, PhD

  3. Institut für Medizinische Psychologie Zentrum für Public Health der, Medizinischen Universität Wien, Severingasse 9, 1090, Wien, Austria

    Ulrich Kropiunigg Prof. Dr.

Authors
  1. Jerzy Leszek Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrzej Kiejna Prof. Dr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Michael Hemmeter MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ulrich Kropiunigg Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Postfach 3244, 4002, Basel, Switzerland

    Sabine Bährer-Kohler

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Leszek, J., Kiejna, A., Hemmeter, U.M., Kropiunigg, U. (2009). Alzheimer. In: Bährer-Kohler, S. (eds) Self Management of Chronic Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00326-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-00326-4_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-00325-7

  • Online ISBN: 978-3-642-00326-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation